6-K - I-Mab | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

I-Mab filed a Form 6-K on February 19, 2026, with no specific items disclosed. The filing contains only basic report information including type and date.

Key Takeaways

1Report type: 6-K

2Filing date: 2026-02-19

3Items: N/A

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

$50.0K$300.0KdirectorsClarus Ventures, a life sciences venture capital firm that he joined at its formation in 2006 and where he served as a Managing Director prior to the acquisition. Prior to joining Clarus Ventures, Dr. Cunningham served as Senior Vice President, Medical Strategy at Eyetech Pharmaceuticals, Inc.

Exhibits (2)

6-K

99.1

EX-99.1